BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Arthur Klausner to speak at "NC Early-Stage Breakfast" in Raleigh, NC.
News | 11. 14. 2007
